Status:
COMPLETED
Ureteral Stent Placement After Ureteroscopy for Renal Stones: A Randomized Controlled Trial
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
Université de Montréal
University of California, Davis
Conditions:
Kidney Calculi
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The rationale for this study is to determine if there is a difference in complications among patients undergoing ureteroscopy for renal stones who receive a stent compared to not receiving a stent pos...
Detailed Description
Kidney stones affect 9% individuals within the United States, and the prevalence is increasing. Over the last few decades, ureteroscopy has become the most commonly performed stone procedure. However ...
Eligibility Criteria
Inclusion
- nonobstructing renal stone 1.5cm total stone diameter (if multiple stones, then sum of maximum diameters) or less undergoing ureteroscopy
Exclusion
- age \< 18 years
- pregnancy status
- ureteral stone
- preoperative hydronephrosis
- indwelling nephrostomy tube
- planning bilateral ureteroscopy or subsequent staged ureteroscopy
- solitary kidney or eGFR \<60 mL/min (CKD stage 3 or greater)
- variant anatomy including horseshoe kidney, pelvic kidney, prior urinary tract reconstruction
Key Trial Info
Start Date :
November 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2025
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT03855787
Start Date
November 11 2019
End Date
January 1 2025
Last Update
April 13 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Los Angeles
Los Angeles, California, United States, 90095
2
University of California Davis
Sacramento, California, United States, 95817
3
University of California San Diego
San Diego, California, United States, 92121
4
Indiana University Health Physicians Urology
Indianapolis, Indiana, United States, 46202